Basiliximab for the treatment of graft rejection in haploidentical peripheral blood stem cell transplantation.
Messina
G
G
Centro Trapianti di Midollo Osseo e Terapia Sovramassimali Emato-Oncologiche Alberto Neri, Azienda Ospedaliera Bianchi-melacrino-morelli, Reggio Calabria, Italy. gspmessina@virgilio.it
Quartarone
E
E
Fujo
M
M
Irrera
G
G
Console
G
G
Martino
M
M
Mandaglio
R
R
Morabito
F
F
Iacopino
P
P
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000077552:Basiliximab; D006084:Graft Rejection / Q000188:drug therapy*; D006239:Haplotypes; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D015479:Leukemia, Myelomonocytic, Acute / Q000628:therapy; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D011993:Recombinant Fusion Proteins; D014184:Transplantation, Homologous / Q000276:immunology
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab